Abstract：
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a symptom that is a frequent reason for consultation in endocrinology. Thyroid nodules are very common and mostly benign. Thyroid ultrasound and thyroid fine-needle aspiration biopsy (FNAB) are the reference tests for the analysis of these nodules. The aim of this article is to describe for the cytopathologist the key points of the SFE-AFCE-SFMN 2022 consensus involving thyroid cytology: the indications for thyroid FNAB, the technique and analysis, and the management (treatment, follow-up) following this cytological screening examination, a key element in the management of the thyroid nodule.
摘要：
SFE-AFCE-SFMN2022共识涉及甲状腺结节的管理，这种症状是内分泌学咨询的常见原因。甲状腺结节非常常见，大多为良性。甲状腺超声和甲状腺细针穿刺活检（FNAB）是分析这些结节的参考测试。本文的目的是为细胞病理学家描述涉及甲状腺细胞学的SFE-AFCE-SFMN2022共识的要点：甲状腺FNAB的适应症，技术和分析，和管理(治疗，随访)在进行细胞学筛查检查后，甲状腺结节管理的关键因素。
